DK2457581T3 - Sammensætning omfattende CNP eller BNP for et udvendigt præparat til hud til behandling af dermatitis - Google Patents
Sammensætning omfattende CNP eller BNP for et udvendigt præparat til hud til behandling af dermatitisInfo
- Publication number
- DK2457581T3 DK2457581T3 DK10802352.4T DK10802352T DK2457581T3 DK 2457581 T3 DK2457581 T3 DK 2457581T3 DK 10802352 T DK10802352 T DK 10802352T DK 2457581 T3 DK2457581 T3 DK 2457581T3
- Authority
- DK
- Denmark
- Prior art keywords
- cnp
- gdp
- dermatitis
- treatment
- composition
- Prior art date
Links
- 201000004624 Dermatitis Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2242—Atrial natriuretic factor complex: Atriopeptins, atrial natriuretic protein [ANP]; Cardionatrin, Cardiodilatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Birds (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009172589 | 2009-07-23 | ||
| JP2010134600 | 2010-06-11 | ||
| PCT/JP2010/062459 WO2011010732A1 (ja) | 2009-07-23 | 2010-07-23 | 皮膚外用剤組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2457581T3 true DK2457581T3 (da) | 2014-03-31 |
Family
ID=43499204
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK10802352.4T DK2457581T3 (da) | 2009-07-23 | 2010-07-23 | Sammensætning omfattende CNP eller BNP for et udvendigt præparat til hud til behandling af dermatitis |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US20120208756A1 (enExample) |
| EP (1) | EP2457581B1 (enExample) |
| JP (5) | JP4834190B2 (enExample) |
| KR (2) | KR101533695B1 (enExample) |
| CN (4) | CN105999230B (enExample) |
| AU (1) | AU2010274293B9 (enExample) |
| BR (1) | BR112012001491B1 (enExample) |
| CA (1) | CA2768810C (enExample) |
| DK (1) | DK2457581T3 (enExample) |
| ES (1) | ES2456502T3 (enExample) |
| MX (1) | MX2012001024A (enExample) |
| NZ (1) | NZ597797A (enExample) |
| RU (2) | RU2572694C2 (enExample) |
| WO (1) | WO2011010732A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2457581B1 (en) * | 2009-07-23 | 2014-01-08 | Igisu Co., Ltd. | Composition comprising cnp or bnp for external preparation for skin for the treatment of dermatitis |
| BR112013018679B1 (pt) | 2011-01-21 | 2022-04-12 | Igisu Co. Ltd. | Agente para o tratamento da alopecia e uso de um peptídeo natriurético do tipo c |
| ES2488740B1 (es) * | 2012-10-10 | 2015-06-11 | J. Álvaro GALIANO RAMOS | Formulación cosmética y dermatologica para el alivio del prurito |
| CN104367925A (zh) * | 2014-11-07 | 2015-02-25 | 济南高达信息技术有限公司 | 一种治疗红皮病的中药洗剂及其制备方法 |
| TW201708247A (zh) | 2015-05-29 | 2017-03-01 | Igisu Co Ltd | 環狀胜肽及含該環狀胜肽之藥物、外用劑及化粧品 |
| US10722461B2 (en) | 2015-06-19 | 2020-07-28 | Global Health Solutions, Llc | Petrolatum-based delivery systems and for active ingredients |
| EP3689897A1 (en) * | 2015-07-31 | 2020-08-05 | Igisu Co., Ltd. | A cnp cyclic peptide and a medicament, external preparation and cosmetic containing the cyclic peptide |
| CN105617360B (zh) * | 2015-12-04 | 2018-12-21 | 中国农业大学 | C-型钠肽在制备外用避孕药和精子功能检测试剂中的应用 |
| EP3452024A1 (en) * | 2016-05-05 | 2019-03-13 | Aquestive Therapeutics, Inc. | Pharmaceutical compositions with enhanced permeation |
| CN122182527A (zh) | 2016-05-05 | 2026-06-12 | 阿奎斯蒂弗医疗股份有限公司 | 增强递送的肾上腺素组合物 |
| WO2018056907A1 (en) * | 2016-09-21 | 2018-03-29 | Agency For Science, Technology And Research | Methods and compositions for inhibiting skin inflammation and determining cancer susceptibility |
| JP7125862B2 (ja) * | 2018-05-29 | 2022-08-25 | 小林製薬株式会社 | 外用組成物 |
| JP2019214520A (ja) * | 2018-06-12 | 2019-12-19 | 花王株式会社 | 角層剥離改善剤 |
| CN110302194B (zh) * | 2019-07-23 | 2023-01-31 | 广州市皮肤病防治所(广州市性病防治监测中心) | 一种具有抗炎和皮肤屏障保护作用的桉叶素联合糖皮质激素的复方制剂 |
| US11419917B2 (en) | 2020-04-07 | 2022-08-23 | Drora Shevy | Treatment for SARS-CoV-2 and other coronaviruses |
| WO2023076281A1 (en) | 2021-10-25 | 2023-05-04 | Aquestive Therapeutics, Inc. | Oral and nasal compositions and methods of treatment |
| JP7466939B2 (ja) * | 2022-08-31 | 2024-04-15 | 東洋ビューティ株式会社 | Ｏ／ｄ相組成物及び水中油型乳化組成物 |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5114923A (en) | 1988-05-31 | 1992-05-19 | California Biotechnology Inc. | Recombinant techniques for production of novel natriuretic and vasodilator peptides |
| JP2809533B2 (ja) * | 1991-01-31 | 1998-10-08 | 壽之 松尾 | Ｃｎｐ類似体ペプチド |
| JPH05207891A (ja) | 1991-03-08 | 1993-08-20 | Shionogi & Co Ltd | 脳性ナトリウム利尿ペプチドの製造方法 |
| AU6360394A (en) | 1993-03-03 | 1994-09-26 | Mayo Foundation For Medical Education And Research | Vasonatrin peptide and analogs thereof |
| US6028055A (en) | 1996-10-22 | 2000-02-22 | Genetech, Inc. | Receptor selective BNP |
| US5965533A (en) | 1997-05-23 | 1999-10-12 | Baxter International Inc. | Atrial natriuretic peptide (ANP) as an additive to peritoneal dialysis solutions |
| JP3799465B2 (ja) | 1998-09-28 | 2006-07-19 | 参天製薬株式会社 | ナトリウム利尿ペプチドを有効成分とする涙液分泌促進または角結膜障害治療用点眼剤 |
| EP1118329A4 (en) | 1998-09-28 | 2004-12-15 | Santen Pharmaceutical Co Ltd | LACRYMAL SECRETION PROMOTERS OR OPHTHALMOLOGICAL DROPS CONTAINING NATRIURETIC PEPTIDES AS ACTIVE INGREDIENTS FOR TREATING KERATOCONJUNCTIVITY |
| US6407211B1 (en) * | 1999-12-17 | 2002-06-18 | Mayo Foundation For Medical Education And Research | Chimeric natriuretic peptides |
| IL142118A0 (en) | 2001-03-20 | 2002-03-10 | Prochon Biotech Ltd | Method and composition for treatment of skeletal dysplasias |
| JP3676707B2 (ja) * | 2001-07-18 | 2005-07-27 | 三菱電機株式会社 | 車両用交流発電機の固定子およびその製造方法 |
| AU2003268531A1 (en) | 2002-09-06 | 2004-03-29 | University Of South Florida | Materials and methods for treatment of allergic diseases |
| US20050271596A1 (en) | 2002-10-25 | 2005-12-08 | Foamix Ltd. | Vasoactive kit and composition and uses thereof |
| SG159387A1 (en) | 2002-11-26 | 2010-03-30 | Biocon Ltd In | Modified natriuretic compounds, conjugates, and uses thereof |
| US7648962B2 (en) * | 2002-11-26 | 2010-01-19 | Biocon Limited | Natriuretic compounds, conjugates, and uses thereof |
| US20040161435A1 (en) * | 2003-02-14 | 2004-08-19 | Gupta Shyam K. | Skin Firming Anti-Aging Cosmetic Mask Compositions |
| CA2528883A1 (en) | 2003-06-13 | 2004-12-23 | Daiichi Asubio Pharma Co., Ltd. | Pharmaceutical compositions for preventing or treating th1-mediated immune diseases |
| CN101208353B (zh) | 2003-06-20 | 2011-12-14 | 梅约医学教育与研究基金会 | 脑利尿钠肽的同种型 |
| AU2005207886A1 (en) | 2004-01-27 | 2005-08-11 | Compugen Usa, Inc. | Novel brain natriuretic peptide variants and methods of use thereof |
| JP2007525213A (ja) | 2004-01-27 | 2007-09-06 | コンピュゲン ユーエスエイ，インク． | 新規の脳性ナトリウム利尿ペプチドの変異体及びその利用方法 |
| ES2465141T3 (es) | 2004-03-31 | 2014-06-05 | Kazuwa Nakao | Remedio o medicamento preventivo para la artritis |
| KR20070007842A (ko) | 2004-03-31 | 2007-01-16 | 카즈와 나카오 | 신장증가용 조성물 |
| MX2007001667A (es) | 2004-08-11 | 2007-10-02 | Johnson & Johnson | Aparato y metodo para el suministro transdermico de peptidos natriureticos. |
| DE102004048576A1 (de) * | 2004-10-04 | 2006-04-13 | Deutsches Zentrum für Luft- und Raumfahrt e.V. | Methode zur Bräunung der Haut |
| EP1810716A1 (de) * | 2005-12-23 | 2007-07-25 | Deutsches Zentrum für Luft- und Raumfahrt e.V. | Verfahren zur Bräunung der Haut |
| US8324162B2 (en) | 2006-08-08 | 2012-12-04 | Mayo Foundation For Medical Education And Research | Diuretic and natriuretic polypeptides lacking the blood pressure lowering property |
| JPWO2008032450A1 (ja) | 2006-09-15 | 2010-01-21 | 国立大学法人京都大学 | 脂肪肝の予防剤および／または治療剤 |
| US20120034183A1 (en) | 2006-12-19 | 2012-02-09 | Michael Cohen | Compositions and methods for growing embryonic stem cells |
| JP5010913B2 (ja) | 2006-12-31 | 2012-08-29 | 寿子 小出 | 心房利尿ホルモンファミリー分子を活性物質として含有する組織再生製剤また該製剤をもちいる組織再生方法、および心房利尿ホルモンファミリー分子を活性物質として含有する発毛、増毛、育毛剤および皮膚組織修復改善剤また該製剤を用いる発毛、増毛、育毛促進方法および皮膚組織修復改善方法 |
| JP2010168283A (ja) | 2007-04-24 | 2010-08-05 | Yamaguchi Univ | ナトリウム利尿ペプチドを有効成分とする肝硬変・前癌病変の抑制剤 |
| JP5207316B2 (ja) | 2007-05-10 | 2013-06-12 | 国立大学法人名古屋大学 | 腹膜線維化抑制用医薬組成物 |
| KR20100057063A (ko) * | 2007-09-11 | 2010-05-28 | 몬도바이오테크 래보래토리즈 아게 | 치료제로서의 펩티드의 용도 |
| US20100204107A1 (en) | 2007-09-11 | 2010-08-12 | Dorian Bevec | Use of urodilatin as a therapeutic agent |
| AR069409A1 (es) * | 2007-11-21 | 2010-01-20 | Biomarin Pharm Inc | Variantes de peptidos natriureticos de tipo c |
| DK2307447T3 (da) | 2008-07-02 | 2016-06-20 | Mayo Foundation | Natriuretiske polypeptider med unikke farmakologiske profiler |
| US8642550B2 (en) * | 2008-10-24 | 2014-02-04 | Mayo Foundation For Medical Education And Research | Chimeric natriuretic peptides without hypotensive inducing capability |
| US8150603B2 (en) | 2008-11-26 | 2012-04-03 | Caterpillar Inc. | Engine control system having fuel-based timing |
| WO2010078325A2 (en) | 2008-12-29 | 2010-07-08 | Mayo Foundation For Medical Education And Research | Natriuretic polypeptides for reducing or preventing restenosis |
| EP2432489B1 (en) | 2009-05-20 | 2016-10-05 | BioMarin Pharmaceutical Inc. | Variants of c-type natriuretic peptide |
| EP2457581B1 (en) | 2009-07-23 | 2014-01-08 | Igisu Co., Ltd. | Composition comprising cnp or bnp for external preparation for skin for the treatment of dermatitis |
| JP2011024973A (ja) * | 2009-07-24 | 2011-02-10 | Mitsumasa Maeda | 電子ペーパー付き便蓋 |
| WO2011024973A1 (ja) | 2009-08-27 | 2011-03-03 | 株式会社 イギス | 鼻炎治療剤 |
| ITPG20090061A1 (it) | 2009-11-27 | 2011-05-28 | Andrea Marcantonini | Impianto mobile per la produzione di calcestruzzo |
| BR112013018679B1 (pt) | 2011-01-21 | 2022-04-12 | Igisu Co. Ltd. | Agente para o tratamento da alopecia e uso de um peptídeo natriurético do tipo c |
-
2010
- 2010-07-23 EP EP10802352.4A patent/EP2457581B1/en active Active
- 2010-07-23 CN CN201610329663.7A patent/CN105999230B/zh active Active
- 2010-07-23 NZ NZ597797A patent/NZ597797A/xx unknown
- 2010-07-23 RU RU2012103653/15A patent/RU2572694C2/ru active
- 2010-07-23 CA CA2768810A patent/CA2768810C/en active Active
- 2010-07-23 CN CN201910657053.3A patent/CN110339346B/zh active Active
- 2010-07-23 DK DK10802352.4T patent/DK2457581T3/da active
- 2010-07-23 US US13/386,528 patent/US20120208756A1/en not_active Abandoned
- 2010-07-23 WO PCT/JP2010/062459 patent/WO2011010732A1/ja not_active Ceased
- 2010-07-23 CN CN201410324381.9A patent/CN104189893B/zh active Active
- 2010-07-23 JP JP2011507738A patent/JP4834190B2/ja active Active
- 2010-07-23 MX MX2012001024A patent/MX2012001024A/es active IP Right Grant
- 2010-07-23 AU AU2010274293A patent/AU2010274293B9/en not_active Ceased
- 2010-07-23 KR KR1020127027521A patent/KR101533695B1/ko active Active
- 2010-07-23 KR KR1020117017629A patent/KR101226165B1/ko active Active
- 2010-07-23 ES ES10802352.4T patent/ES2456502T3/es active Active
- 2010-07-23 CN CN201080032443.9A patent/CN102470163B/zh active Active
- 2010-07-23 BR BR112012001491-9A patent/BR112012001491B1/pt not_active IP Right Cessation
-
2011
- 2011-02-18 JP JP2011033976A patent/JP5778440B2/ja active Active
-
2013
- 2013-09-03 US US14/016,637 patent/US9358269B2/en active Active
-
2015
- 2015-07-09 JP JP2015137445A patent/JP6055518B2/ja active Active
-
2016
- 2016-01-22 RU RU2015150099A patent/RU2015150099A/ru not_active Application Discontinuation
- 2016-05-06 US US15/148,470 patent/US9968654B2/en active Active
- 2016-12-02 JP JP2016234905A patent/JP6337071B2/ja active Active
-
2017
- 2017-12-11 US US15/837,964 patent/US10946072B2/en active Active
-
2018
- 2018-05-07 JP JP2018089006A patent/JP2018135381A/ja not_active Withdrawn
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2448637T3 (da) | Anvendelse af ét fytocannabinoid eller en kombination af fytocannabinoider til behandling af epilepsi | |
| DK2451796T3 (da) | Tofaanaloger til behandling af dermatologiske lidelser eller tilstande | |
| DK2819602T3 (da) | Kateter til behandling af atrieflagren med enkelt-virkende dobbelt afbøjningsmekanisme | |
| DK2635282T3 (da) | Sammensætninger til behandling af myelofibrose | |
| DK2451482T3 (da) | Kombinationsterapi til behandlingen af diabetes | |
| ZA201403795B (en) | Formulations for the treatment of diabetes | |
| IL229474B (en) | Cannabinoids for use in the treatment of neuropathic pain | |
| DK2459553T3 (da) | Furazanobenzimidazoler som prodrug til behandling af neoplastiske eller autoimmune sygdomme | |
| DK3581199T3 (da) | Fremgangsmåder til behandling eller reduktion af ødematøs fibrosklerotisk pannikulitis | |
| BRPI0907950A2 (pt) | Tratamento de hiperglicemia com 25-hidroxivitamina d3 | |
| DK2522342T3 (da) | Topisk formulering til behandling af hyperkeratonisk hud | |
| DK2839004T3 (da) | Fremgangsmåde til at behandle diabetes og/eller fremme overlevelse af langerhanske øer efter transplantation | |
| DK2588620T3 (da) | Fremgangsmåde til fremstilling af butanol eller acetone | |
| DK2407151T3 (da) | Sammensætning til behandling af hud- og/eller neglelæsioner | |
| DK2470202T3 (da) | Clostridium-neurotoksiner til anvendelse i behandling af præmatur ejakulation | |
| BR112013033732A2 (pt) | composição de revestimento de fibra de vidro | |
| EP2494966A4 (en) | STABLE COMPOSITION OF RASAGILINE | |
| DK2646011T3 (da) | Fremgangsmåder til reduktion af overspisning eller tvangsspisning | |
| DK3446565T3 (da) | Fremgangsmåder til behandling af antipsykotika-induceret vægtøgning | |
| DK2462108T3 (da) | Fremgangsmåde til fremstilling af pyrazolcarboxylsyreamider | |
| EP2507309A4 (en) | NETWORKING RESOURCES | |
| SG11201402849PA (en) | Composition containing tangeretin for external application to the skin | |
| DOP2012000313A (es) | Cristal de compuesto de amida | |
| DK2705847T3 (da) | Sammensætning til behandling af psoriasis | |
| DK2701707T3 (da) | Fremgangsmåde til behandling af dyskinesi |